(Q36847302)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

A systematic review of economic analyses of pharmaceutical therapies for advanced colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Miriam Koopman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Carin Uyl-de Groot

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Cornelis J A Punt

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563265%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Pharmacotherapy

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

1313-1328

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563265%20AND%20SRC:MED&resulttype=core&format=json

ABC of colorectal cancer: treatment of advanced disease

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

New options and old dilemmas in the treatment of patients with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

The price tag on progress--chemotherapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Cost-effectiveness analysis of colorectal cancer treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Costs of treatment of colorectal cancer in different settings in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Cost-benefit analysis of capecitabine versus 5-fluorouracil/leucovorin in the treatment of colorectal cancer in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Pharmaco-economic comparative evaluation of combination chronotherapy vs. standard chemotherapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Costs incurred by patients undergoing advanced colorectal cancer therapy. A comparison of raltitrexed and fluorouracil plus folinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Clinical and economic benefits of irinotecan in combination with 5-fluorouracil and folinic acid as first line treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Two schedules of second-line irinotecan for metastatic colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Mature results from three large controlled studies with raltitrexed ('Tomudex').

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Systemic therapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Two steps forward in the treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Answering patients' needs: oral alternatives to intravenous therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma: a randomized comparison of two regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

A 'modified de Gramont' regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Capecitabine as first-line treatment in colorectal cancer. Pooled data from two large, phase III trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Irinotecan in second-line treatment of metastatic colorectal cancer: improved survival and cost-effect compared with infusional 5-FU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

Early detection of toxicity and adjustment of ongoing clinical trials: the history and performance of the North Central Cancer Treatment Group's real-time toxicity monitoring program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.9.1313

10.1517/14656566.8.9.1313

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17563265%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference